nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—Bifonazole—Letrozole—breast cancer	0.242	0.605	CrCrCtD
Oxaprozin—PTGS1—breast cancer	0.19	0.636	CbGaD
Oxaprozin—PTGS2—breast cancer	0.108	0.364	CbGaD
Oxaprozin—CYP2C9—Anastrozole—breast cancer	0.0403	0.332	CbGbCtD
Oxaprozin—CYP2C9—Idarubicin—breast cancer	0.0306	0.252	CbGbCtD
Oxaprozin—Benzphetamine—Toremifene—breast cancer	0.0296	0.074	CrCrCtD
Oxaprozin—Benzyl Benzoate—Toremifene—breast cancer	0.0274	0.0686	CrCrCtD
Oxaprozin—Diphenhydramine—Toremifene—breast cancer	0.0263	0.0657	CrCrCtD
Oxaprozin—Methadone—Tamoxifen—breast cancer	0.0222	0.0556	CrCrCtD
Oxaprozin—Benzphetamine—Tamoxifen—breast cancer	0.0186	0.0465	CrCrCtD
Oxaprozin—Benzyl Benzoate—Tamoxifen—breast cancer	0.0172	0.0431	CrCrCtD
Oxaprozin—CYP2C9—Capecitabine—breast cancer	0.0167	0.138	CbGbCtD
Oxaprozin—Diphenhydramine—Tamoxifen—breast cancer	0.0165	0.0413	CrCrCtD
Oxaprozin—CYP2C9—Tamoxifen—breast cancer	0.0135	0.111	CbGbCtD
Oxaprozin—CYP2C9—Paclitaxel—breast cancer	0.0105	0.0863	CbGbCtD
Oxaprozin—CYP2C9—Fluorouracil—breast cancer	0.00993	0.0817	CbGbCtD
Oxaprozin—Bifonazole—CYP17A1—breast cancer	0.00032	0.132	CrCbGaD
Oxaprozin—Fenbufen—PTGS1—breast cancer	0.000191	0.0788	CrCbGaD
Oxaprozin—Bifonazole—CYP19A1—breast cancer	0.000163	0.067	CrCbGaD
Oxaprozin—CYP2C9—mammary gland—breast cancer	0.000121	0.084	CbGeAlD
Oxaprozin—Phenylbutazone—PTGS1—breast cancer	0.00011	0.0452	CrCbGaD
Oxaprozin—Fenbufen—PTGS2—breast cancer	0.000109	0.045	CrCbGaD
Oxaprozin—Warfarin—CYP1A1—breast cancer	9.59e-05	0.0396	CrCbGaD
Oxaprozin—PTGS1—nipple—breast cancer	9.15e-05	0.0634	CbGeAlD
Oxaprozin—Flurbiprofen—PTGS1—breast cancer	8.95e-05	0.0369	CrCbGaD
Oxaprozin—Bifonazole—CYP3A4—breast cancer	7.63e-05	0.0315	CrCbGaD
Oxaprozin—PTGS2—embryo—breast cancer	7.21e-05	0.05	CbGeAlD
Oxaprozin—Methadone—CYP19A1—breast cancer	7.16e-05	0.0295	CrCbGaD
Oxaprozin—Propafenone—CYP2D6—breast cancer	6.98e-05	0.0288	CrCbGaD
Oxaprozin—Phenprocoumon—CYP3A4—breast cancer	6.9e-05	0.0285	CrCbGaD
Oxaprozin—Phenylbutazone—CYP3A4—breast cancer	6.41e-05	0.0264	CrCbGaD
Oxaprozin—Phenylbutazone—PTGS2—breast cancer	6.27e-05	0.0259	CrCbGaD
Oxaprozin—PTGS1—epithelium—breast cancer	6.16e-05	0.0427	CbGeAlD
Oxaprozin—Warfarin—CYP3A4—breast cancer	6.12e-05	0.0253	CrCbGaD
Oxaprozin—Phenprocoumon—ALB—breast cancer	6.02e-05	0.0248	CrCbGaD
Oxaprozin—Propafenone—CYP3A4—breast cancer	5.99e-05	0.0247	CrCbGaD
Oxaprozin—Diphenhydramine—PTGS1—breast cancer	5.97e-05	0.0246	CrCbGaD
Oxaprozin—PTGS2—epithelium—breast cancer	5.89e-05	0.0408	CbGeAlD
Oxaprozin—PTGS1—skin of body—breast cancer	5.86e-05	0.0406	CbGeAlD
Oxaprozin—PTGS2—skin of body—breast cancer	5.6e-05	0.0388	CbGeAlD
Oxaprozin—PTGS1—endometrium—breast cancer	5.52e-05	0.0383	CbGeAlD
Oxaprozin—Clorazepate—CYP3A4—breast cancer	5.39e-05	0.0222	CrCbGaD
Oxaprozin—Warfarin—ALB—breast cancer	5.34e-05	0.022	CrCbGaD
Oxaprozin—PTGS2—endometrium—breast cancer	5.28e-05	0.0366	CbGeAlD
Oxaprozin—Flurbiprofen—PTGS2—breast cancer	5.12e-05	0.0211	CrCbGaD
Oxaprozin—PTGS1—uterus—breast cancer	5.09e-05	0.0353	CbGeAlD
Oxaprozin—Modafinil—CYP3A4—breast cancer	5.02e-05	0.0207	CrCbGaD
Oxaprozin—CYP2C9—female reproductive system—breast cancer	5.01e-05	0.0347	CbGeAlD
Oxaprozin—PTGS1—pituitary gland—breast cancer	5e-05	0.0347	CbGeAlD
Oxaprozin—Propafenone—ABCB1—breast cancer	4.98e-05	0.0205	CrCbGaD
Oxaprozin—PTGS1—adipose tissue—breast cancer	4.98e-05	0.0345	CbGeAlD
Oxaprozin—PTGS2—uterus—breast cancer	4.86e-05	0.0337	CbGeAlD
Oxaprozin—PTGS2—pituitary gland—breast cancer	4.78e-05	0.0331	CbGeAlD
Oxaprozin—PTGS2—adipose tissue—breast cancer	4.76e-05	0.033	CbGeAlD
Oxaprozin—Carbamazepine—CYP3A4—breast cancer	4.58e-05	0.0189	CrCbGaD
Oxaprozin—PTGS1—female reproductive system—breast cancer	4.57e-05	0.0317	CbGeAlD
Oxaprozin—Flurbiprofen—ALB—breast cancer	4.56e-05	0.0188	CrCbGaD
Oxaprozin—PTGS1—adrenal gland—breast cancer	4.46e-05	0.031	CbGeAlD
Oxaprozin—Phenytoin—CYP3A4—breast cancer	4.45e-05	0.0183	CrCbGaD
Oxaprozin—PTGS2—female reproductive system—breast cancer	4.37e-05	0.0303	CbGeAlD
Oxaprozin—Benzphetamine—CYP3A4—breast cancer	4.35e-05	0.0179	CrCbGaD
Oxaprozin—PTGS2—adrenal gland—breast cancer	4.27e-05	0.0296	CbGeAlD
Oxaprozin—CYP2C9—endocrine gland—breast cancer	4.24e-05	0.0294	CbGeAlD
Oxaprozin—PTGS1—female gonad—breast cancer	4.16e-05	0.0289	CbGeAlD
Oxaprozin—PTGS2—bone marrow—breast cancer	4.13e-05	0.0286	CbGeAlD
Oxaprozin—Diphenhydramine—CYP2D6—breast cancer	4.06e-05	0.0168	CrCbGaD
Oxaprozin—PTGS2—female gonad—breast cancer	3.98e-05	0.0276	CbGeAlD
Oxaprozin—Drowsiness—Doxorubicin—breast cancer	3.94e-05	0.000295	CcSEcCtD
Oxaprozin—Confusional state—Capecitabine—breast cancer	3.93e-05	0.000295	CcSEcCtD
Oxaprozin—Tachycardia—Docetaxel—breast cancer	3.93e-05	0.000295	CcSEcCtD
Oxaprozin—Methadone—CYP2D6—breast cancer	3.92e-05	0.0162	CrCbGaD
Oxaprozin—Feeling abnormal—Paclitaxel—breast cancer	3.92e-05	0.000293	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Doxorubicin—breast cancer	3.91e-05	0.000293	CcSEcCtD
Oxaprozin—Oedema—Capecitabine—breast cancer	3.9e-05	0.000292	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Paclitaxel—breast cancer	3.89e-05	0.000291	CcSEcCtD
Oxaprozin—Diarrhoea—Gemcitabine—breast cancer	3.88e-05	0.000291	CcSEcCtD
Oxaprozin—Phenytoin—ALB—breast cancer	3.88e-05	0.016	CrCbGaD
Oxaprozin—Renal failure—Doxorubicin—breast cancer	3.87e-05	0.00029	CcSEcCtD
Oxaprozin—Infection—Capecitabine—breast cancer	3.87e-05	0.00029	CcSEcCtD
Oxaprozin—PTGS1—endocrine gland—breast cancer	3.87e-05	0.0268	CbGeAlD
Oxaprozin—Erythema multiforme—Methotrexate—breast cancer	3.86e-05	0.00029	CcSEcCtD
Oxaprozin—Dizziness—Irinotecan—breast cancer	3.85e-05	0.000289	CcSEcCtD
Oxaprozin—Haemoglobin—Epirubicin—breast cancer	3.84e-05	0.000288	CcSEcCtD
Oxaprozin—Stomatitis—Doxorubicin—breast cancer	3.84e-05	0.000288	CcSEcCtD
Oxaprozin—Jaundice—Doxorubicin—breast cancer	3.84e-05	0.000288	CcSEcCtD
Oxaprozin—Anorexia—Docetaxel—breast cancer	3.84e-05	0.000288	CcSEcCtD
Oxaprozin—Shock—Capecitabine—breast cancer	3.84e-05	0.000288	CcSEcCtD
Oxaprozin—Conjunctivitis—Doxorubicin—breast cancer	3.83e-05	0.000287	CcSEcCtD
Oxaprozin—Haemorrhage—Epirubicin—breast cancer	3.82e-05	0.000287	CcSEcCtD
Oxaprozin—Hepatitis—Epirubicin—breast cancer	3.82e-05	0.000287	CcSEcCtD
Oxaprozin—Diarrhoea—Fluorouracil—breast cancer	3.82e-05	0.000286	CcSEcCtD
Oxaprozin—Thrombocytopenia—Capecitabine—breast cancer	3.82e-05	0.000286	CcSEcCtD
Oxaprozin—Carbamazepine—ABCB1—breast cancer	3.81e-05	0.0157	CrCbGaD
Oxaprozin—Tinnitus—Methotrexate—breast cancer	3.81e-05	0.000286	CcSEcCtD
Oxaprozin—Tachycardia—Capecitabine—breast cancer	3.81e-05	0.000285	CcSEcCtD
Oxaprozin—Urticaria—Paclitaxel—breast cancer	3.77e-05	0.000283	CcSEcCtD
Oxaprozin—Hyperhidrosis—Capecitabine—breast cancer	3.77e-05	0.000283	CcSEcCtD
Oxaprozin—Hypotension—Docetaxel—breast cancer	3.76e-05	0.000282	CcSEcCtD
Oxaprozin—Haematuria—Doxorubicin—breast cancer	3.76e-05	0.000282	CcSEcCtD
Oxaprozin—Abdominal pain—Paclitaxel—breast cancer	3.76e-05	0.000282	CcSEcCtD
Oxaprozin—Body temperature increased—Paclitaxel—breast cancer	3.76e-05	0.000282	CcSEcCtD
Oxaprozin—Anorexia—Capecitabine—breast cancer	3.72e-05	0.000279	CcSEcCtD
Oxaprozin—Vomiting—Irinotecan—breast cancer	3.7e-05	0.000278	CcSEcCtD
Oxaprozin—Vomiting—Mitoxantrone—breast cancer	3.7e-05	0.000278	CcSEcCtD
Oxaprozin—Phenytoin—ABCB1—breast cancer	3.7e-05	0.0153	CrCbGaD
Oxaprozin—PTGS2—endocrine gland—breast cancer	3.7e-05	0.0257	CbGeAlD
Oxaprozin—Sinusitis—Doxorubicin—breast cancer	3.7e-05	0.000277	CcSEcCtD
Oxaprozin—Dizziness—Fluorouracil—breast cancer	3.69e-05	0.000277	CcSEcCtD
Oxaprozin—Agranulocytosis—Doxorubicin—breast cancer	3.68e-05	0.000276	CcSEcCtD
Oxaprozin—Rash—Irinotecan—breast cancer	3.67e-05	0.000275	CcSEcCtD
Oxaprozin—Rash—Mitoxantrone—breast cancer	3.67e-05	0.000275	CcSEcCtD
Oxaprozin—Dermatitis—Mitoxantrone—breast cancer	3.67e-05	0.000275	CcSEcCtD
Oxaprozin—Dermatitis—Irinotecan—breast cancer	3.67e-05	0.000275	CcSEcCtD
Oxaprozin—Headache—Mitoxantrone—breast cancer	3.65e-05	0.000274	CcSEcCtD
Oxaprozin—Headache—Irinotecan—breast cancer	3.65e-05	0.000274	CcSEcCtD
Oxaprozin—Hypotension—Capecitabine—breast cancer	3.64e-05	0.000273	CcSEcCtD
Oxaprozin—Insomnia—Docetaxel—breast cancer	3.64e-05	0.000273	CcSEcCtD
Oxaprozin—Paraesthesia—Docetaxel—breast cancer	3.62e-05	0.000271	CcSEcCtD
Oxaprozin—Erythema multiforme—Epirubicin—breast cancer	3.62e-05	0.000271	CcSEcCtD
Oxaprozin—Alopecia—Methotrexate—breast cancer	3.61e-05	0.000271	CcSEcCtD
Oxaprozin—Vomiting—Gemcitabine—breast cancer	3.61e-05	0.00027	CcSEcCtD
Oxaprozin—Dyspnoea—Docetaxel—breast cancer	3.59e-05	0.000269	CcSEcCtD
Oxaprozin—Somnolence—Docetaxel—breast cancer	3.58e-05	0.000268	CcSEcCtD
Oxaprozin—Rash—Gemcitabine—breast cancer	3.58e-05	0.000268	CcSEcCtD
Oxaprozin—Dermatitis—Gemcitabine—breast cancer	3.58e-05	0.000268	CcSEcCtD
Oxaprozin—Tinnitus—Epirubicin—breast cancer	3.57e-05	0.000267	CcSEcCtD
Oxaprozin—Haemoglobin—Doxorubicin—breast cancer	3.56e-05	0.000267	CcSEcCtD
Oxaprozin—Headache—Gemcitabine—breast cancer	3.56e-05	0.000266	CcSEcCtD
Oxaprozin—Vomiting—Fluorouracil—breast cancer	3.55e-05	0.000266	CcSEcCtD
Oxaprozin—Dyspepsia—Docetaxel—breast cancer	3.55e-05	0.000266	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—breast cancer	3.54e-05	0.000265	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—breast cancer	3.54e-05	0.000265	CcSEcCtD
Oxaprozin—Insomnia—Capecitabine—breast cancer	3.53e-05	0.000264	CcSEcCtD
Oxaprozin—Rash—Fluorouracil—breast cancer	3.52e-05	0.000264	CcSEcCtD
Oxaprozin—Dermatitis—Fluorouracil—breast cancer	3.52e-05	0.000263	CcSEcCtD
Oxaprozin—Paraesthesia—Capecitabine—breast cancer	3.5e-05	0.000262	CcSEcCtD
Oxaprozin—Decreased appetite—Docetaxel—breast cancer	3.5e-05	0.000262	CcSEcCtD
Oxaprozin—Headache—Fluorouracil—breast cancer	3.5e-05	0.000262	CcSEcCtD
Oxaprozin—Dysgeusia—Methotrexate—breast cancer	3.48e-05	0.000261	CcSEcCtD
Oxaprozin—Dyspnoea—Capecitabine—breast cancer	3.48e-05	0.000261	CcSEcCtD
Oxaprozin—Nausea—Irinotecan—breast cancer	3.46e-05	0.000259	CcSEcCtD
Oxaprozin—Nausea—Mitoxantrone—breast cancer	3.46e-05	0.000259	CcSEcCtD
Oxaprozin—Constipation—Docetaxel—breast cancer	3.44e-05	0.000258	CcSEcCtD
Oxaprozin—Dyspepsia—Capecitabine—breast cancer	3.43e-05	0.000257	CcSEcCtD
Oxaprozin—Arrhythmia—Epirubicin—breast cancer	3.42e-05	0.000256	CcSEcCtD
Oxaprozin—Asthenia—Paclitaxel—breast cancer	3.41e-05	0.000256	CcSEcCtD
Oxaprozin—Decreased appetite—Capecitabine—breast cancer	3.39e-05	0.000254	CcSEcCtD
Oxaprozin—Alopecia—Epirubicin—breast cancer	3.38e-05	0.000253	CcSEcCtD
Oxaprozin—Nausea—Gemcitabine—breast cancer	3.37e-05	0.000253	CcSEcCtD
Oxaprozin—Methadone—CYP3A4—breast cancer	3.36e-05	0.0139	CrCbGaD
Oxaprozin—Pruritus—Paclitaxel—breast cancer	3.36e-05	0.000252	CcSEcCtD
Oxaprozin—Vision blurred—Methotrexate—breast cancer	3.35e-05	0.000251	CcSEcCtD
Oxaprozin—Erythema multiforme—Doxorubicin—breast cancer	3.35e-05	0.000251	CcSEcCtD
Oxaprozin—Constipation—Capecitabine—breast cancer	3.33e-05	0.00025	CcSEcCtD
Oxaprozin—Feeling abnormal—Docetaxel—breast cancer	3.32e-05	0.000249	CcSEcCtD
Oxaprozin—Nausea—Fluorouracil—breast cancer	3.31e-05	0.000248	CcSEcCtD
Oxaprozin—Ill-defined disorder—Methotrexate—breast cancer	3.3e-05	0.000247	CcSEcCtD
Oxaprozin—Tinnitus—Doxorubicin—breast cancer	3.3e-05	0.000247	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Docetaxel—breast cancer	3.29e-05	0.000247	CcSEcCtD
Oxaprozin—Anaemia—Methotrexate—breast cancer	3.29e-05	0.000246	CcSEcCtD
Oxaprozin—Flatulence—Epirubicin—breast cancer	3.28e-05	0.000246	CcSEcCtD
Oxaprozin—Tension—Epirubicin—breast cancer	3.27e-05	0.000245	CcSEcCtD
Oxaprozin—Dysgeusia—Epirubicin—breast cancer	3.26e-05	0.000244	CcSEcCtD
Oxaprozin—Diarrhoea—Paclitaxel—breast cancer	3.25e-05	0.000244	CcSEcCtD
Oxaprozin—Nervousness—Epirubicin—breast cancer	3.23e-05	0.000242	CcSEcCtD
Oxaprozin—Feeling abnormal—Capecitabine—breast cancer	3.21e-05	0.000241	CcSEcCtD
Oxaprozin—Malaise—Methotrexate—breast cancer	3.21e-05	0.00024	CcSEcCtD
Oxaprozin—Vertigo—Methotrexate—breast cancer	3.2e-05	0.000239	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Capecitabine—breast cancer	3.19e-05	0.000239	CcSEcCtD
Oxaprozin—Abdominal pain—Docetaxel—breast cancer	3.18e-05	0.000239	CcSEcCtD
Oxaprozin—Body temperature increased—Docetaxel—breast cancer	3.18e-05	0.000239	CcSEcCtD
Oxaprozin—Leukopenia—Methotrexate—breast cancer	3.18e-05	0.000239	CcSEcCtD
Oxaprozin—Arrhythmia—Doxorubicin—breast cancer	3.16e-05	0.000237	CcSEcCtD
Oxaprozin—Dizziness—Paclitaxel—breast cancer	3.14e-05	0.000235	CcSEcCtD
Oxaprozin—Vision blurred—Epirubicin—breast cancer	3.14e-05	0.000235	CcSEcCtD
Oxaprozin—Alopecia—Doxorubicin—breast cancer	3.13e-05	0.000234	CcSEcCtD
Oxaprozin—Urticaria—Capecitabine—breast cancer	3.1e-05	0.000232	CcSEcCtD
Oxaprozin—Ill-defined disorder—Epirubicin—breast cancer	3.09e-05	0.000231	CcSEcCtD
Oxaprozin—Body temperature increased—Capecitabine—breast cancer	3.08e-05	0.000231	CcSEcCtD
Oxaprozin—Abdominal pain—Capecitabine—breast cancer	3.08e-05	0.000231	CcSEcCtD
Oxaprozin—Convulsion—Methotrexate—breast cancer	3.08e-05	0.000231	CcSEcCtD
Oxaprozin—Anaemia—Epirubicin—breast cancer	3.08e-05	0.000231	CcSEcCtD
Oxaprozin—Flatulence—Doxorubicin—breast cancer	3.03e-05	0.000227	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—breast cancer	3.02e-05	0.000227	CcSEcCtD
Oxaprozin—Vomiting—Paclitaxel—breast cancer	3.02e-05	0.000226	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—breast cancer	3.02e-05	0.000226	CcSEcCtD
Oxaprozin—Malaise—Epirubicin—breast cancer	3e-05	0.000225	CcSEcCtD
Oxaprozin—Rash—Paclitaxel—breast cancer	3e-05	0.000225	CcSEcCtD
Oxaprozin—Dermatitis—Paclitaxel—breast cancer	2.99e-05	0.000224	CcSEcCtD
Oxaprozin—Discomfort—Methotrexate—breast cancer	2.99e-05	0.000224	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—breast cancer	2.99e-05	0.000224	CcSEcCtD
Oxaprozin—Vertigo—Epirubicin—breast cancer	2.99e-05	0.000224	CcSEcCtD
Oxaprozin—Syncope—Epirubicin—breast cancer	2.98e-05	0.000224	CcSEcCtD
Oxaprozin—Leukopenia—Epirubicin—breast cancer	2.98e-05	0.000223	CcSEcCtD
Oxaprozin—Headache—Paclitaxel—breast cancer	2.98e-05	0.000223	CcSEcCtD
Oxaprozin—Palpitations—Epirubicin—breast cancer	2.94e-05	0.00022	CcSEcCtD
Oxaprozin—Confusional state—Methotrexate—breast cancer	2.93e-05	0.000219	CcSEcCtD
Oxaprozin—Loss of consciousness—Epirubicin—breast cancer	2.93e-05	0.000219	CcSEcCtD
Oxaprozin—Anaphylactic shock—Methotrexate—breast cancer	2.9e-05	0.000218	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—breast cancer	2.9e-05	0.000218	CcSEcCtD
Oxaprozin—Asthenia—Docetaxel—breast cancer	2.89e-05	0.000217	CcSEcCtD
Oxaprozin—Convulsion—Epirubicin—breast cancer	2.88e-05	0.000216	CcSEcCtD
Oxaprozin—Infection—Methotrexate—breast cancer	2.88e-05	0.000216	CcSEcCtD
Oxaprozin—Hypertension—Epirubicin—breast cancer	2.87e-05	0.000215	CcSEcCtD
Oxaprozin—Ill-defined disorder—Doxorubicin—breast cancer	2.86e-05	0.000214	CcSEcCtD
Oxaprozin—Pruritus—Docetaxel—breast cancer	2.85e-05	0.000214	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—breast cancer	2.85e-05	0.000213	CcSEcCtD
Oxaprozin—Thrombocytopenia—Methotrexate—breast cancer	2.84e-05	0.000213	CcSEcCtD
Oxaprozin—Anxiety—Epirubicin—breast cancer	2.82e-05	0.000212	CcSEcCtD
Oxaprozin—Nausea—Paclitaxel—breast cancer	2.82e-05	0.000212	CcSEcCtD
Oxaprozin—Hyperhidrosis—Methotrexate—breast cancer	2.81e-05	0.00021	CcSEcCtD
Oxaprozin—Methadone—ABCB1—breast cancer	2.8e-05	0.0115	CrCbGaD
Oxaprozin—Discomfort—Epirubicin—breast cancer	2.8e-05	0.00021	CcSEcCtD
Oxaprozin—Asthenia—Capecitabine—breast cancer	2.8e-05	0.00021	CcSEcCtD
Oxaprozin—Malaise—Doxorubicin—breast cancer	2.78e-05	0.000208	CcSEcCtD
Oxaprozin—Dry mouth—Epirubicin—breast cancer	2.77e-05	0.000208	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—breast cancer	2.77e-05	0.000207	CcSEcCtD
Oxaprozin—Anorexia—Methotrexate—breast cancer	2.77e-05	0.000207	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—breast cancer	2.76e-05	0.000207	CcSEcCtD
Oxaprozin—Pruritus—Capecitabine—breast cancer	2.76e-05	0.000207	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—breast cancer	2.76e-05	0.000207	CcSEcCtD
Oxaprozin—Diarrhoea—Docetaxel—breast cancer	2.76e-05	0.000207	CcSEcCtD
Oxaprozin—Confusional state—Epirubicin—breast cancer	2.74e-05	0.000205	CcSEcCtD
Oxaprozin—Palpitations—Doxorubicin—breast cancer	2.72e-05	0.000204	CcSEcCtD
Oxaprozin—Oedema—Epirubicin—breast cancer	2.72e-05	0.000204	CcSEcCtD
Oxaprozin—Anaphylactic shock—Epirubicin—breast cancer	2.72e-05	0.000204	CcSEcCtD
Oxaprozin—Hypotension—Methotrexate—breast cancer	2.71e-05	0.000203	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—breast cancer	2.71e-05	0.000203	CcSEcCtD
Oxaprozin—Infection—Epirubicin—breast cancer	2.7e-05	0.000202	CcSEcCtD
Oxaprozin—PTGS1—lymph node—breast cancer	2.68e-05	0.0186	CbGeAlD
Oxaprozin—Shock—Epirubicin—breast cancer	2.67e-05	0.0002	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—breast cancer	2.67e-05	0.0002	CcSEcCtD
Oxaprozin—Diarrhoea—Capecitabine—breast cancer	2.67e-05	0.0002	CcSEcCtD
Oxaprozin—Dizziness—Docetaxel—breast cancer	2.66e-05	0.0002	CcSEcCtD
Oxaprozin—Thrombocytopenia—Epirubicin—breast cancer	2.66e-05	0.000199	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—breast cancer	2.66e-05	0.000199	CcSEcCtD
Oxaprozin—Tachycardia—Epirubicin—breast cancer	2.65e-05	0.000199	CcSEcCtD
Oxaprozin—Hyperhidrosis—Epirubicin—breast cancer	2.63e-05	0.000197	CcSEcCtD
Oxaprozin—Insomnia—Methotrexate—breast cancer	2.63e-05	0.000197	CcSEcCtD
Oxaprozin—Anxiety—Doxorubicin—breast cancer	2.61e-05	0.000196	CcSEcCtD
Oxaprozin—Paraesthesia—Methotrexate—breast cancer	2.61e-05	0.000195	CcSEcCtD
Oxaprozin—Discomfort—Doxorubicin—breast cancer	2.59e-05	0.000194	CcSEcCtD
Oxaprozin—Anorexia—Epirubicin—breast cancer	2.59e-05	0.000194	CcSEcCtD
Oxaprozin—Dyspnoea—Methotrexate—breast cancer	2.59e-05	0.000194	CcSEcCtD
Oxaprozin—Somnolence—Methotrexate—breast cancer	2.58e-05	0.000193	CcSEcCtD
Oxaprozin—Dizziness—Capecitabine—breast cancer	2.58e-05	0.000193	CcSEcCtD
Oxaprozin—Dry mouth—Doxorubicin—breast cancer	2.56e-05	0.000192	CcSEcCtD
Oxaprozin—Vomiting—Docetaxel—breast cancer	2.56e-05	0.000192	CcSEcCtD
Oxaprozin—PTGS2—lymph node—breast cancer	2.56e-05	0.0177	CbGeAlD
Oxaprozin—Dyspepsia—Methotrexate—breast cancer	2.56e-05	0.000192	CcSEcCtD
Oxaprozin—Rash—Docetaxel—breast cancer	2.54e-05	0.00019	CcSEcCtD
Oxaprozin—Hypotension—Epirubicin—breast cancer	2.54e-05	0.00019	CcSEcCtD
Oxaprozin—Dermatitis—Docetaxel—breast cancer	2.54e-05	0.00019	CcSEcCtD
Oxaprozin—Confusional state—Doxorubicin—breast cancer	2.53e-05	0.00019	CcSEcCtD
Oxaprozin—Decreased appetite—Methotrexate—breast cancer	2.52e-05	0.000189	CcSEcCtD
Oxaprozin—Headache—Docetaxel—breast cancer	2.52e-05	0.000189	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—breast cancer	2.51e-05	0.000188	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—breast cancer	2.51e-05	0.000188	CcSEcCtD
Oxaprozin—Infection—Doxorubicin—breast cancer	2.5e-05	0.000187	CcSEcCtD
Oxaprozin—Vomiting—Capecitabine—breast cancer	2.48e-05	0.000186	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—breast cancer	2.47e-05	0.000185	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—breast cancer	2.46e-05	0.000184	CcSEcCtD
Oxaprozin—Rash—Capecitabine—breast cancer	2.46e-05	0.000184	CcSEcCtD
Oxaprozin—Insomnia—Epirubicin—breast cancer	2.46e-05	0.000184	CcSEcCtD
Oxaprozin—Dermatitis—Capecitabine—breast cancer	2.46e-05	0.000184	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—breast cancer	2.45e-05	0.000184	CcSEcCtD
Oxaprozin—Headache—Capecitabine—breast cancer	2.44e-05	0.000183	CcSEcCtD
Oxaprozin—Paraesthesia—Epirubicin—breast cancer	2.44e-05	0.000183	CcSEcCtD
Oxaprozin—Hyperhidrosis—Doxorubicin—breast cancer	2.43e-05	0.000182	CcSEcCtD
Oxaprozin—Dyspnoea—Epirubicin—breast cancer	2.42e-05	0.000182	CcSEcCtD
Oxaprozin—Somnolence—Epirubicin—breast cancer	2.42e-05	0.000181	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—breast cancer	2.4e-05	0.00018	CcSEcCtD
Oxaprozin—Nausea—Docetaxel—breast cancer	2.39e-05	0.000179	CcSEcCtD
Oxaprozin—Feeling abnormal—Methotrexate—breast cancer	2.39e-05	0.000179	CcSEcCtD
Oxaprozin—Dyspepsia—Epirubicin—breast cancer	2.39e-05	0.000179	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Methotrexate—breast cancer	2.37e-05	0.000178	CcSEcCtD
Oxaprozin—Decreased appetite—Epirubicin—breast cancer	2.36e-05	0.000177	CcSEcCtD
Oxaprozin—Hypotension—Doxorubicin—breast cancer	2.35e-05	0.000176	CcSEcCtD
Oxaprozin—Constipation—Epirubicin—breast cancer	2.32e-05	0.000174	CcSEcCtD
Oxaprozin—Nausea—Capecitabine—breast cancer	2.32e-05	0.000174	CcSEcCtD
Oxaprozin—Urticaria—Methotrexate—breast cancer	2.31e-05	0.000173	CcSEcCtD
Oxaprozin—Abdominal pain—Methotrexate—breast cancer	2.29e-05	0.000172	CcSEcCtD
Oxaprozin—Body temperature increased—Methotrexate—breast cancer	2.29e-05	0.000172	CcSEcCtD
Oxaprozin—Insomnia—Doxorubicin—breast cancer	2.27e-05	0.00017	CcSEcCtD
Oxaprozin—Paraesthesia—Doxorubicin—breast cancer	2.26e-05	0.000169	CcSEcCtD
Oxaprozin—Dyspnoea—Doxorubicin—breast cancer	2.24e-05	0.000168	CcSEcCtD
Oxaprozin—Feeling abnormal—Epirubicin—breast cancer	2.24e-05	0.000168	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—breast cancer	2.23e-05	0.000167	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Epirubicin—breast cancer	2.22e-05	0.000166	CcSEcCtD
Oxaprozin—Dyspepsia—Doxorubicin—breast cancer	2.21e-05	0.000166	CcSEcCtD
Oxaprozin—Decreased appetite—Doxorubicin—breast cancer	2.19e-05	0.000164	CcSEcCtD
Oxaprozin—Urticaria—Epirubicin—breast cancer	2.16e-05	0.000162	CcSEcCtD
Oxaprozin—Constipation—Doxorubicin—breast cancer	2.15e-05	0.000161	CcSEcCtD
Oxaprozin—Abdominal pain—Epirubicin—breast cancer	2.15e-05	0.000161	CcSEcCtD
Oxaprozin—Body temperature increased—Epirubicin—breast cancer	2.15e-05	0.000161	CcSEcCtD
Oxaprozin—Asthenia—Methotrexate—breast cancer	2.08e-05	0.000156	CcSEcCtD
Oxaprozin—Feeling abnormal—Doxorubicin—breast cancer	2.07e-05	0.000155	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Doxorubicin—breast cancer	2.06e-05	0.000154	CcSEcCtD
Oxaprozin—Pruritus—Methotrexate—breast cancer	2.05e-05	0.000154	CcSEcCtD
Oxaprozin—Urticaria—Doxorubicin—breast cancer	2e-05	0.00015	CcSEcCtD
Oxaprozin—Body temperature increased—Doxorubicin—breast cancer	1.99e-05	0.000149	CcSEcCtD
Oxaprozin—Abdominal pain—Doxorubicin—breast cancer	1.99e-05	0.000149	CcSEcCtD
Oxaprozin—Diarrhoea—Methotrexate—breast cancer	1.99e-05	0.000149	CcSEcCtD
Oxaprozin—Asthenia—Epirubicin—breast cancer	1.95e-05	0.000146	CcSEcCtD
Oxaprozin—Pruritus—Epirubicin—breast cancer	1.92e-05	0.000144	CcSEcCtD
Oxaprozin—Dizziness—Methotrexate—breast cancer	1.92e-05	0.000144	CcSEcCtD
Oxaprozin—Diarrhoea—Epirubicin—breast cancer	1.86e-05	0.000139	CcSEcCtD
Oxaprozin—Vomiting—Methotrexate—breast cancer	1.85e-05	0.000138	CcSEcCtD
Oxaprozin—Rash—Methotrexate—breast cancer	1.83e-05	0.000137	CcSEcCtD
Oxaprozin—Dermatitis—Methotrexate—breast cancer	1.83e-05	0.000137	CcSEcCtD
Oxaprozin—Headache—Methotrexate—breast cancer	1.82e-05	0.000136	CcSEcCtD
Oxaprozin—Asthenia—Doxorubicin—breast cancer	1.8e-05	0.000135	CcSEcCtD
Oxaprozin—Dizziness—Epirubicin—breast cancer	1.8e-05	0.000135	CcSEcCtD
Oxaprozin—Pruritus—Doxorubicin—breast cancer	1.78e-05	0.000133	CcSEcCtD
Oxaprozin—Vomiting—Epirubicin—breast cancer	1.73e-05	0.000129	CcSEcCtD
Oxaprozin—Nausea—Methotrexate—breast cancer	1.72e-05	0.000129	CcSEcCtD
Oxaprozin—Diarrhoea—Doxorubicin—breast cancer	1.72e-05	0.000129	CcSEcCtD
Oxaprozin—Rash—Epirubicin—breast cancer	1.71e-05	0.000128	CcSEcCtD
Oxaprozin—Dermatitis—Epirubicin—breast cancer	1.71e-05	0.000128	CcSEcCtD
Oxaprozin—Headache—Epirubicin—breast cancer	1.7e-05	0.000128	CcSEcCtD
Oxaprozin—Dizziness—Doxorubicin—breast cancer	1.66e-05	0.000125	CcSEcCtD
Oxaprozin—Nausea—Epirubicin—breast cancer	1.61e-05	0.000121	CcSEcCtD
Oxaprozin—Vomiting—Doxorubicin—breast cancer	1.6e-05	0.00012	CcSEcCtD
Oxaprozin—Rash—Doxorubicin—breast cancer	1.58e-05	0.000119	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—breast cancer	1.58e-05	0.000119	CcSEcCtD
Oxaprozin—Headache—Doxorubicin—breast cancer	1.57e-05	0.000118	CcSEcCtD
Oxaprozin—Nausea—Doxorubicin—breast cancer	1.49e-05	0.000112	CcSEcCtD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.03e-05	0.000239	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NCOA2—breast cancer	1.02e-05	0.000237	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—DPYD—breast cancer	1.02e-05	0.000236	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MED12—breast cancer	1.02e-05	0.000236	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.02e-05	0.000235	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALDH7A1—breast cancer	1.01e-05	0.000235	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALDH1A1—breast cancer	1.01e-05	0.000235	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ENO1—breast cancer	1.01e-05	0.000233	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1e-05	0.000232	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALDOA—breast cancer	1e-05	0.000232	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—FASN—breast cancer	9.91e-06	0.00023	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—BCHE—breast cancer	9.87e-06	0.000229	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC5A5—breast cancer	9.75e-06	0.000226	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOA3—breast cancer	9.72e-06	0.000225	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NME1—breast cancer	9.72e-06	0.000225	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—FHL2—breast cancer	9.72e-06	0.000225	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PHGDH—breast cancer	9.72e-06	0.000225	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ADSL—breast cancer	9.72e-06	0.000225	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—UMPS—breast cancer	9.72e-06	0.000225	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC2A2—breast cancer	9.65e-06	0.000224	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	9.55e-06	0.000221	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—BRIP1—breast cancer	9.53e-06	0.000221	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HPSE—breast cancer	9.53e-06	0.000221	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LDHB—breast cancer	9.53e-06	0.000221	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF3—breast cancer	9.52e-06	0.00022	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CPT1A—breast cancer	9.46e-06	0.000219	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCG2—breast cancer	9.46e-06	0.000219	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTR—breast cancer	9.46e-06	0.000219	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC2A1—breast cancer	9.42e-06	0.000218	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NQO1—breast cancer	9.42e-06	0.000218	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FASN—breast cancer	9.4e-06	0.000218	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—JAG1—breast cancer	9.4e-06	0.000218	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PARP1—breast cancer	9.36e-06	0.000217	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HPGDS—breast cancer	9.28e-06	0.000215	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CALCA—breast cancer	9.24e-06	0.000214	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	9.22e-06	0.000214	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HBA1—breast cancer	9.22e-06	0.000213	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP3A4—breast cancer	9.18e-06	0.000213	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	9.14e-06	0.000212	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPS6—breast cancer	9.13e-06	0.000212	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF4—breast cancer	9.06e-06	0.00021	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HMMR—breast cancer	9.04e-06	0.000209	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCC1—breast cancer	9.04e-06	0.000209	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA3—breast cancer	9.04e-06	0.000209	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP1B1—breast cancer	9.03e-06	0.000209	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CXCR4—breast cancer	9.03e-06	0.000209	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTT1—breast cancer	9e-06	0.000208	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ACHE—breast cancer	9e-06	0.000208	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SLC2A1—breast cancer	8.93e-06	0.000207	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HSP90AA1—breast cancer	8.85e-06	0.000205	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PPARGC1B—breast cancer	8.75e-06	0.000203	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	8.73e-06	0.000202	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TCF7L2—breast cancer	8.71e-06	0.000202	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NCOA1—breast cancer	8.61e-06	0.000199	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	8.52e-06	0.000197	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	8.52e-06	0.000197	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP17A1—breast cancer	8.52e-06	0.000197	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP19A1—breast cancer	8.49e-06	0.000197	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—STK11—breast cancer	8.49e-06	0.000197	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ENO1—breast cancer	8.43e-06	0.000195	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PTGS1—breast cancer	8.43e-06	0.000195	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.4e-06	0.000195	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HSP90AA1—breast cancer	8.39e-06	0.000194	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.29e-06	0.000192	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2D6—breast cancer	8.27e-06	0.000191	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA4—breast cancer	8.26e-06	0.000191	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CA9—breast cancer	8.26e-06	0.000191	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PRL—breast cancer	8.17e-06	0.000189	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	8.16e-06	0.000189	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOA2—breast cancer	8.11e-06	0.000188	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	8.08e-06	0.000187	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GPX2—breast cancer	8.05e-06	0.000187	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA2—breast cancer	8.05e-06	0.000187	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ADAM10—breast cancer	8.05e-06	0.000186	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.97e-06	0.000185	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GPX4—breast cancer	7.96e-06	0.000184	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SULT1A1—breast cancer	7.96e-06	0.000184	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—COMT—breast cancer	7.89e-06	0.000183	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—FASN—breast cancer	7.87e-06	0.000182	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTP1—breast cancer	7.85e-06	0.000182	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—BCHE—breast cancer	7.84e-06	0.000182	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF10—breast cancer	7.83e-06	0.000181	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA1—breast cancer	7.77e-06	0.00018	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—IDH1—breast cancer	7.77e-06	0.00018	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HMOX1—breast cancer	7.75e-06	0.000179	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC5A5—breast cancer	7.74e-06	0.000179	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ITPR1—breast cancer	7.73e-06	0.000179	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NAT2—breast cancer	7.68e-06	0.000178	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PDGFA—breast cancer	7.55e-06	0.000175	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC2A1—breast cancer	7.48e-06	0.000173	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NQO1—breast cancer	7.48e-06	0.000173	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TGFBR2—breast cancer	7.45e-06	0.000172	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ABCB1—breast cancer	7.44e-06	0.000172	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ITPR1—breast cancer	7.33e-06	0.00017	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.32e-06	0.00017	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TYMS—breast cancer	7.3e-06	0.000169	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP3A4—breast cancer	7.29e-06	0.000169	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STAT5A—breast cancer	7.28e-06	0.000169	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERBB4—breast cancer	7.28e-06	0.000169	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTM1—breast cancer	7.22e-06	0.000167	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NCOR1—breast cancer	7.22e-06	0.000167	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PLA2G4A—breast cancer	7.22e-06	0.000167	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP1B1—breast cancer	7.17e-06	0.000166	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SMAD4—breast cancer	7.05e-06	0.000163	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HSP90AA1—breast cancer	7.03e-06	0.000163	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	6.95e-06	0.000161	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GPX1—breast cancer	6.91e-06	0.00016	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HES1—breast cancer	6.88e-06	0.000159	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP1A1—breast cancer	6.84e-06	0.000158	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NCOR1—breast cancer	6.84e-06	0.000158	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOA1—breast cancer	6.84e-06	0.000158	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ERCC2—breast cancer	6.79e-06	0.000157	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF1—breast cancer	6.77e-06	0.000157	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—STK11—breast cancer	6.74e-06	0.000156	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP19A1—breast cancer	6.74e-06	0.000156	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MED12—breast cancer	6.74e-06	0.000156	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—DPYD—breast cancer	6.74e-06	0.000156	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NRG1—breast cancer	6.72e-06	0.000156	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—H2AFX—breast cancer	6.67e-06	0.000154	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALDOA—breast cancer	6.63e-06	0.000154	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOA3—breast cancer	6.44e-06	0.000149	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERCC2—breast cancer	6.43e-06	0.000149	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC2A2—breast cancer	6.39e-06	0.000148	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MTHFR—breast cancer	6.38e-06	0.000148	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	6.33e-06	0.000147	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.33e-06	0.000147	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERBB3—breast cancer	6.29e-06	0.000146	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGFR2—breast cancer	6.28e-06	0.000145	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—COMT—breast cancer	6.27e-06	0.000145	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CPT1A—breast cancer	6.26e-06	0.000145	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTR—breast cancer	6.26e-06	0.000145	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCG2—breast cancer	6.26e-06	0.000145	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTP1—breast cancer	6.24e-06	0.000144	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HMOX1—breast cancer	6.15e-06	0.000142	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HPGDS—breast cancer	6.14e-06	0.000142	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ITPR1—breast cancer	6.14e-06	0.000142	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HBA1—breast cancer	6.1e-06	0.000141	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTHFR—breast cancer	6.05e-06	0.00014	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TERT—breast cancer	6.03e-06	0.00014	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTT1—breast cancer	5.96e-06	0.000138	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ACHE—breast cancer	5.96e-06	0.000138	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCB1—breast cancer	5.9e-06	0.000137	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CAV1—breast cancer	5.88e-06	0.000136	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGFR1—breast cancer	5.86e-06	0.000136	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TYMS—breast cancer	5.8e-06	0.000134	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HIF1A—breast cancer	5.77e-06	0.000134	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PLA2G4A—breast cancer	5.73e-06	0.000133	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOR1—breast cancer	5.73e-06	0.000133	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTM1—breast cancer	5.73e-06	0.000133	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP17A1—breast cancer	5.64e-06	0.000131	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.62e-06	0.00013	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ENO1—breast cancer	5.58e-06	0.000129	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTGS1—breast cancer	5.58e-06	0.000129	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CAV1—breast cancer	5.58e-06	0.000129	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.56e-06	0.000129	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.49e-06	0.000127	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GPX1—breast cancer	5.49e-06	0.000127	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2D6—breast cancer	5.47e-06	0.000127	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP1A1—breast cancer	5.43e-06	0.000126	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ERCC2—breast cancer	5.39e-06	0.000125	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOA2—breast cancer	5.37e-06	0.000124	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CG—breast cancer	5.36e-06	0.000124	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NOS2—breast cancer	5.25e-06	0.000121	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—FASN—breast cancer	5.21e-06	0.000121	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NOTCH1—breast cancer	5.2e-06	0.00012	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—BCHE—breast cancer	5.19e-06	0.00012	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC5A5—breast cancer	5.13e-06	0.000119	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APC—breast cancer	5.08e-06	0.000118	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KIT—breast cancer	5.08e-06	0.000118	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTHFR—breast cancer	5.06e-06	0.000117	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EGF—breast cancer	5.02e-06	0.000116	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC2A1—breast cancer	4.95e-06	0.000115	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NQO1—breast cancer	4.95e-06	0.000115	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.85e-06	0.000112	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP3A4—breast cancer	4.83e-06	0.000112	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.8e-06	0.000111	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BRAF—breast cancer	4.78e-06	0.000111	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP1B1—breast cancer	4.75e-06	0.00011	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CD—breast cancer	4.71e-06	0.000109	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CAV1—breast cancer	4.67e-06	0.000108	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HSP90AA1—breast cancer	4.65e-06	0.000108	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALB—breast cancer	4.65e-06	0.000108	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKT2—breast cancer	4.65e-06	0.000108	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOA1—breast cancer	4.53e-06	0.000105	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CD—breast cancer	4.47e-06	0.000103	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—STK11—breast cancer	4.46e-06	0.000103	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP19A1—breast cancer	4.46e-06	0.000103	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.46e-06	0.000103	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NOS3—breast cancer	4.45e-06	0.000103	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SERPINE1—breast cancer	4.42e-06	0.000102	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CG—breast cancer	4.25e-06	9.85e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NOS3—breast cancer	4.22e-06	9.77e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.19e-06	9.7e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—COMT—breast cancer	4.15e-06	9.61e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTP1—breast cancer	4.13e-06	9.56e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CB—breast cancer	4.11e-06	9.51e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HMOX1—breast cancer	4.07e-06	9.43e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTGS2—breast cancer	4.07e-06	9.42e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ITPR1—breast cancer	4.06e-06	9.41e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MDM2—breast cancer	4e-06	9.27e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RAF1—breast cancer	3.99e-06	9.23e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERBB2—breast cancer	3.94e-06	9.14e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCB1—breast cancer	3.91e-06	9.05e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTOR—breast cancer	3.89e-06	9.02e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CB—breast cancer	3.89e-06	9.02e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD4—breast cancer	3.89e-06	9e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TYMS—breast cancer	3.84e-06	8.89e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.79e-06	8.79e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTM1—breast cancer	3.79e-06	8.79e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOR1—breast cancer	3.79e-06	8.79e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CD—breast cancer	3.74e-06	8.66e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALB—breast cancer	3.69e-06	8.55e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN1B—breast cancer	3.65e-06	8.46e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GPX1—breast cancer	3.63e-06	8.42e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP1A1—breast cancer	3.6e-06	8.33e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ERCC2—breast cancer	3.57e-06	8.26e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTEN—breast cancer	3.55e-06	8.22e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NOS3—breast cancer	3.53e-06	8.18e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CTNNB1—breast cancer	3.45e-06	7.99e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN1A—breast cancer	3.37e-06	7.81e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PTEN—breast cancer	3.36e-06	7.79e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTHFR—breast cancer	3.35e-06	7.77e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CB—breast cancer	3.26e-06	7.55e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SRC—breast cancer	3.12e-06	7.23e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CAV1—breast cancer	3.09e-06	7.16e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STAT3—breast cancer	3.01e-06	6.97e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.96e-06	6.84e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAPK3—breast cancer	2.87e-06	6.66e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CG—breast cancer	2.82e-06	6.53e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PTEN—breast cancer	2.82e-06	6.52e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MYC—breast cancer	2.8e-06	6.47e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TGFB1—breast cancer	2.79e-06	6.46e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EGFR—breast cancer	2.73e-06	6.33e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KRAS—breast cancer	2.58e-06	5.98e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CA—breast cancer	2.5e-06	5.8e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CD—breast cancer	2.48e-06	5.74e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALB—breast cancer	2.45e-06	5.66e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CA—breast cancer	2.37e-06	5.5e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NOS3—breast cancer	2.34e-06	5.42e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HRAS—breast cancer	2.2e-06	5.09e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CB—breast cancer	2.16e-06	5e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTGS2—breast cancer	2.14e-06	4.95e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6—breast cancer	2.1e-06	4.87e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKT1—breast cancer	2.05e-06	4.74e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CA—breast cancer	1.99e-06	4.6e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKT1—breast cancer	1.94e-06	4.49e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTEN—breast cancer	1.87e-06	4.32e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKT1—breast cancer	1.62e-06	3.76e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CA—breast cancer	1.32e-06	3.05e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKT1—breast cancer	1.08e-06	2.49e-05	CbGpPWpGaD
